Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |